Divya Chaudhary
University of London · 105 works · 5,281 citations · h-index 22
Top works
- PD-L2 is a second ligand for PD-1 and inhibits T cell activation
- Role of CED-4 in the activation of CED-3
- PD‐1 inhibits T‐cell receptor induced phosphorylation of the ZAP70/CD3ζ signalosome and downstream signaling to PKCθ
- The Death Inhibitory Molecules CED-9 and CED-4L Use a Common Mechanism to Inhibit the CED-3 Death Protease
- Catalytic Domain Crystal Structure of Protein Kinase C-θ (PKCθ)
- Effect of Sources and Levels of Zinc on Growth and Yield of Wheat (Triticum aestivum L.) in Loamy Sand
- IL-33 synergizes with IgE-dependent and IgE-independent agents to promote mast cell and basophil activation
- Selective interleukin-1 receptor–associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy
- PKCtheta: A potential therapeutic target for T-cell-mediated diseases.
- Recent Advances in the Discovery of Small Molecule Inhibitors of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) as a Therapeutic Target for Inflammation and Oncology Disorders
- The c-myc Promoter Binding Protein (MBP-1) and TBP Bind Simultaneously in the Minor Groove of the c-myc P2 Promoter
- A Flexible Synthesis of Indoles from ortho-Substituted Anilines: A Direct Synthesis of Isocryptolepine
- Synthesis and PKCθ inhibitory activity of a series of 4-(indol-5-ylamino)thieno[2,3-b]pyridine-5-carbonitriles
- Identification, Characterization and Initial Hit-to-Lead Optimization of a Series of 4-Arylamino-3-Pyridinecarbonitrile as Protein Kinase C theta (PKCθ) Inhibitors
- 2-Alkenylthieno[2,3-b]pyridine-5-carbonitriles: Potent and selective inhibitors of PKCθ
- Second generation 4-(4-methyl-1H-indol-5-ylamino)-2-phenylthieno[2,3-b]pyridine-5-carbonitrile PKCθ inhibitors
- Accidental Olanzapine Consumption in Children
- Conversion of substituted benzyl ethers to diarylmethanes. A direct synthesis of diarylbenzofurans
- IRAK4 Kinase As A Novel Therapeutic Target in the ABC Subtype of Diffuse Large B Cell Lymphoma
- Synthesis and PKCθ inhibitory activity of a series of 4-indolylamino-5-phenyl-3-pyridinecarbonitriles